sodium channel blockers drugs impair conduction sodium ions na sodium following naturallyproduced substances block sodium channels binding occluding extracellular pore opening channel drugs block sodium channels blocking intracellular side channel include sodium channel blockers used treatment cardiac arrhythmia classified type vaughan williams classification class antiarrhythmic agents interfere na channel class agents grouped effect na channel effect cardiac action potentials class agents called membrane stabilizing agents stabilizing refers decrease excitogenicity plasma membrane affected agents class ii agents propranolol example also membrane stabilizing effect class ia agents block fast sodium channel depresses phase depolarization ie reduces vmax prolongs action potential duration slowing conduction agents class also cause decreased conductivity increased refractoriness indications class ia agents supraventricular tachycardia ventricular tachycardia symptomatic ventricular premature beats prevention ventricular fibrillation procainamide used treat atrial fibrillation setting syndrome treat wide complex hemodynamically stable tachycardias oral procainamide longer manufactured us intravenous formulations still available procainamide quinidine may used conversion atrial fibrillation normal sinus rhythm used conjunction av node blocking agent digoxin verapamil beta blocker procainamide quinidine increase conduction av node may cause conduction atrial fibrillation causing increase ventricular rate class ia agents include quinidine procainamide disopyramide class ib antiarrhythmic agents sodium channel blockers fast onset offset kinetics meaning little effect slower heart rates effects faster heart rates class ib agents shorten action potential duration reduce refractoriness agents decrease vmax partially depolarized cells fast response action potentials either change action potential duration may decrease action potential duration class ib drugs tend specific voltage gated na channels ia lidocaine particular highly frequency dependent activity increasing heart rates lidocaine selectively blocks na channels open inactive states little binding capability resting state class ib agents indicated treatment ventricular tachycardia symptomatic premature ventricular beats prevention ventricular fibrillation class ib agents include lidocaine mexiletine tocainide phenytoin class ic antiarrhythmic agents markedly depress phase depolarization decreasing vmax decrease conductivity minimal effect action potential duration sodium channel blocking antiarrhythmic agents class antiarrhythmic agents class ic agents potent sodium channel blocking effects class ic agents indicated supraventricular arrhythmias ie atrial fibrillation last line treatment refractory lifethreatening ventricular tachycardia ventricular agents potentially proarrhythmic especially settings structural heart disease eg postmyocardial infarction contraindicated settings class ic agents include encainide flecainide moricizine propafenone encainide available united states sodium channel blockers also used local anesthetics sodium channel blockers proposed use treatment cystic current evidence suggested analgesic effects antidepressants may mediated part via sodium channel voltagedependent sodium channel blockers used insecticides comprising insecticide resistance action committee irac mechanism action group march two indoxacarb oxadiazines metaflumizone selective blockers voltagegated sodium channels funapide investigated novel httpsenwikipediaorgwikisodiumchannelblocker